Fibrates: no ACCORD on their use in the treatment of dyslipidaemia. | Curr Opin Lipidol;21(4): 352-8, 2010 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.

Wierzbicki, Anthony S.

Affiliation

Wierzbicki AS; St Thomas' Hospital, London, UK. Anthony.Wierzbicki@kcl.ac.uk

Curr Opin Lipidol ; 21(4): 352-8, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20625256

Subject(s)

Clofibric Acid/therapeutic use; Dyslipidemias/drug therapy; Clinical Trials as Topic; Clofibric Acid/adverse effects; Clofibric Acid/pharmacology; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dyslipidemias/complications; Dyslipidemias/physiopathology; Humans; Microvessels/drug effects

Search on Google

Full text: 1 Database: MEDLINE Main subject: Clofibric Acid / Dyslipidemias Limits: Humans Language: En Year: 2010 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Clofibric Acid / Dyslipidemias Limits: Humans Language: En Year: 2010 Type: Article